Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-19-055289

Options or other derivatives

  • Chief Legal Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BASTA JAMES · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-11-04 Grant or award : show line 1 in the form Option to purchase common stock +175,000 $15.36 2029-11-03 175,000 175,000 D
Loading xslF345X03/doc4.xml…